NASDAQ · Healthcare · Biotechnology
Insmed Incorporated
INSM
Insmed Incorporated operates as a biopharmaceutical enterprise focused on creating and introducing medical solutions for individuals facing severe and uncommon health conditions. CEO William H. Lewis · Market cap $27.1B.
$125.08
-5.58 · -4.27%
52w hi $212.7552w lo $90.39
Off 52w high 37.8%
60
NOTABLE
Current InsiderScore
Corp · 90d
1
0 buys · 1 sales
Cong · 90d
1
0 buys · 1 sales
Signals ≥ 60 · 12mo
1
0 strong · 1 notable
Analyst consensus
Strong Buy
Avg PT $197.43
Section 01
Recent Form 4 filings
21 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Aug 10 | Roger Adsett | Chief Operating Officer | Sell | 239,850 | $133.27 | −$31.96M | 60 |
| May 13 | William Lewis | Chair and CEO | Sell | 13,283 | $116.18 | −$1.54M | 31 |
| Apr 06 | William Lewis | Chair and CEO | Sell | 8,478 | $163.23 | −$1.38M | 35 |
| Apr 01 | Roger Adsett | Chief Operating Officer | Sell | 19,001 | $164.11 | −$3.12M | 38 |
| Apr 01 | Roger Adsett | Chief Operating Officer | Sell | 6,715 | $163.18 | −$1.10M | 32 |
| Apr 01 | Roger Adsett | Chief Operating Officer | Sell | 62,344 | $164.95 | −$10.28M | 52 |
| Dec 05 | Melvin Sharoky MD | Sell | 20,000 | $205.01 | −$4.10M | 25 | |
| Nov 24 | Elizabeth M Anderson | Sell | 5,000 | $204.58 | −$1.02M | 25 | |
| Nov 17 | Leo Lee | Sell | 17,594 | $194.49 | −$3.42M | 28 | |
| Nov 17 | Leo Lee | Sell | 14,944 | $195.39 | −$2.92M | 28 | |
| Nov 17 | Leo Lee | Sell | 24,076 | $196.61 | −$4.73M | 32 | |
| Nov 17 | Leo Lee | Sell | 15,174 | $197.40 | −$3.00M | 28 | |
| Nov 14 | Elizabeth M Anderson | Sell | 10,000 | $195.87 | −$1.96M | 28 | |
| Nov 12 | Orlov S Nicole Schaeffer | Chief People Strategy Officer | Sell | 19,183 | $194.44 | −$3.73M | 34 |
| Nov 12 | Orlov S Nicole Schaeffer | Chief People Strategy Officer | Sell | 6,575 | $193.64 | −$1.27M | 30 |
| Sep 12 | Melvin Sharoky MD | Sell | 10,000 | $145.39 | −$1.45M | 22 | |
| Aug 20 | Melvin Sharoky MD | Sell | 10,000 | $129.50 | −$1.29M | 22 | |
| Aug 19 | Roger Adsett | Chief Operating Officer | Sell | 20,193 | $127.42 | −$2.57M | 34 |
| Aug 12 | Melvin Sharoky MD | Sell | 10,000 | $121.58 | −$1.22M | 22 | |
| May 21 | Clarissa Desjardins | Buy | 1,130 | $66.35 | +$75K | 60 | |
| May 20 | Clarissa Desjardins | Buy | 1,895 | $66.87 | +$127K | 63 |
Section 02
Recent STOCK Act disclosures
1 disclosures on file
| Disclosed | Legislator | Chamber · State | Action | Range | Midpoint | Delay | Score |
|---|---|---|---|---|---|---|---|
| Jul 08 | Josh Gottheimer | House · NJ | Sell | $1,001 - $15,000 | $8K | 28 d | 41 |
Section 03
InsiderScore history
Rolling 12 months · peak score per month
SepOctNovDecJanFebMarAprMayJunJulAug